ChemoMouthpiece, LLC — SEC Form D Filing
ChemoMouthpiece, LLC filed an SEC Form D on October 30, 2026, reporting $400K raised in Other Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 30, 2026
- Amount reported
- $400K
- Round stage
- Seed stage, as indicated by a $400,000 equity raise supporting early commercialization following regulatory clearance.
- Industry
- Other Health Care
- Website
- https://chemomouthpiece.com
What the company does
Securities: Equity. Revenue: $1 - $1,000,000. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Chemotherapy patients frequently suffer from severe and painful oral mucositis that degrades quality of life and can interrupt critical cancer treatment schedules.
Solution
ChemoMouthpiece builds an FDA 510(k)-cleared intraoral cooling device that target-cools the oral cavity to prevent and reduce chemotherapy-induced oral mucositis.
Why now
Recent FDA 510(k) clearance and strategic commercial partnerships enable standard-of-care adoption of controlled oral cryotherapy over imprecise legacy practices.
Source: SEC EDGAR Form D filing